4//SEC Filing
Eizen Joshua M 4
Accession 0000950170-24-083200
CIK 0001880438other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:13 PM ET
Size
17.7 KB
Accession
0000950170-24-083200
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Award
Common Stock
2024-07-10+60,000→ 94,833 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units ("RSUs"). RSUs vest as follows: 25% vest on January 1, 2025, 50% vest on January 1, 2026 and 25% vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
- [F2]Includes a balance of 30,000 RSUs which vest as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F3]Reflects the adjusted total which includes the purchase of 2,386 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2024.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:13 PM ET
- Size
- 17.7 KB